Displaying 1 publication

  1. Bin Abdul Aziz MF, Morrison M, Kaye J
    Regen Med, 2022 Feb;17(2):91-105.
    PMID: 34905952 DOI: 10.2217/rme-2021-0068
    Malaysia aspires to develop regenerative medicine through stem-cell technology. It needs a regulatory system that could facilitate development and prevent unethical practices. A comparative legal analysis on the regulation of stem-cell technology, with a focus on stem-cell research in Malaysia and selected Commonwealth countries that are experienced in regulating this complex technology, demonstrates that the selected Commonwealth countries have adopted a hybrid of different regulatory mechanisms. This paper argues that Malaysia should consider adopting a similar approach to equip relevant authorities with different regulatory mechanisms that are able to promote innovation in stem-cell research activities and cultivate a successful and profitable regenerative medicine industry in the future. Such a strategic action can produce an optimal regulatory outcome and help Malaysia to realize its aspiration.
Related Terms
Contact Us

Please provide feedback to Administrator (tengcl@gmail.com)

External Links